Abstract
Abstract The purpose of this study is to identify groups of firms with similar generic knowledge strategies, determine how these strategies change over time, and compare profit margins of the groups. Knowledge strategies of 21 U.S. pharmaceutical firms are analyzed from 1977 to 1991. Cluster analysis is used to group firms over different time periods based on: (a) balance between internal and external learning, (b) preference for radical or incremental learning, (c) learning speed, and (d) breadth of knowledge base. Our findings indicate that there are four generic knowledge strategy groups: ‘Explorers’, ‘Exploiters’, ‘Loners’, and ‘Innovators’. Most firms remain in the same knowledge group over time. The firms in the ‘Innovator’ and ‘Explorer’ groups tend to be more profitable than the firms in the ‘Exploiter’ and ‘Loner’ groups.
Keywords
InnovatorBusinessProfit (economics)MarketingIndustrial organizationKnowledge managementPreferenceEconomicsMicroeconomicsComputer scienceEntrepreneurshipFinance
Affiliated Institutions
Related Publications
Knowledge of the Firm, Combinative Capabilities, and the Replication of Technology
How should we understand why firms exist? A prevailing view has been that they serve to keep in check the transaction costs arising from the self-interested motivations of indiv...
Prospering in Dynamically-Competitive Environments: Organizational Capability as Knowledge Integration
Unstable market conditions caused by innovation and increasing intensity and diversity of competition have resulted in organizational capabilities rather than served markets bec...
Knowledge Management Processes and International Joint Ventures
The management and processing of organizational knowledge are increasingly being viewed as critical to organizational success. By exploring how firms access and exploit alliance...
What Firms Do? Coordination, Identity, and Learning
Firms are organizations that represent social knowledge of coordination and learning. But why should their boundaries demarcate quantitative shifts in the knowledge and capabili...
Asset Stocks and Sustained Competitive Advantage: A Comment
In their paper, Dierickx and Cool suggest that the strategic factor markets model developed in Barney (Barney, J. B. 1986a. Strategic factor markets: Expectations, luck, and bus...
Publication Info
- Year
- 1996
- Type
- article
- Volume
- 17
- Issue
- S2
- Pages
- 123-135
- Citations
- 880
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
880
OpenAlex
Cite This
Paul E. Bierly,
Alok Chakrabarti
(1996).
Generic knowledge strategies in the U.S. pharmaceutical industry.
Strategic Management Journal
, 17
(S2)
, 123-135.
https://doi.org/10.1002/smj.4250171111
Identifiers
- DOI
- 10.1002/smj.4250171111